AT555809T
Pharmaceutical anti-tnf-alpha antibody formulation
Abstract
This record has no abstract on file.
Term
Term ended
Expired 15 August 2023, 3.1 years ago.
- Priority
- Filed
- Granted
- Expired
- Today
8 priority claims, no other members on record
Priority claims8
| Document | Office | Kind | Date |
|---|---|---|---|
| 22214002 | United States of America | A | |
| 22214002 | United States of America | A | |
| 0304502 | International Bureau of the World Intellectual Property Organization (WIPO) | W | |
| 0304502 | International Bureau of the World Intellectual Property Organization (WIPO) | W | |
| 222140 | – | – | – |
| 0304502 | – | – | – |
| US20020222140 | – | – | – |
| WO2003IB04502 | – | – | – |
Numbers
- Publication, DOCDB
- 555809
- Publication, EPODOC
- AT555809T
- Application
- 3748439
- Application, DOCDB
- 03748439
- Application, EPODOC
- AT20030748439T
Titles2
- German
- PHARMEZEUTISCHE ANTI-TNF-ALPHA ANTIKÖRPER FORMULIERUNG
- English
- PHARMACEUTICAL ANTI-TNF-ALPHA ANTIBODY FORMULATION
Classification
- CPC, 53
- A61K39/39591
- A61K39/395
- A61K9/0019
- C07K2317/21
- A61K47/26
- C07K16/241
- A61P1/00
- C07K2317/76
- A61P1/02
- A61P1/04
- A61P1/16
- C07K2317/94
- A61P1/18
- A61P3/04
- A61P3/10
- A61P7/00
- A61P9/00
- A61P9/04
- A61P11/00
- A61P9/10
- A61P11/06
- A61P13/12
- A61P15/00
- A61P17/00
- A61P17/06
- A61P19/02
- A61P19/04
- A61P19/06
- A61P19/08
- A61P25/02
- A61P25/04
- A61P27/02
- A61P29/00
- A61P31/00
- A61P31/04
- A61P31/12
- A61P31/18
- A61P33/06
- A61P35/00
- A61P37/00
- A61P37/02
- A61P37/06
- A61P37/08
- A61P43/00
- Y02A50/30
- A61K9/19
- A61K39/3955
- A61K2039/505
- C07K2317/92
- A61K47/02
- A61K47/10
- A61K47/12
- A61K47/22
- IPC, 3
- A61K39 395
- A61K9 19
- A61K47 26